Scott Gutz will assume the role on Sept. 16 from Onyx's longtime leader Mark Dubrow, who has decided to retire and focus on his board responsibilities, effective Sept. 30.
Premature babies diagnosed with bronchopulmonary dysplasia (BPD) face the risk of rehospitalization, delayed brain development, and respiratory problems throughout childhood. No FDA-approved therapies are available for BPD—which is why the new FDA designation for AyuVis's drug candidate, AVR-48, could lead to game-changing impact.
Taylor Kennedy Frenchi
Program Manager – Nature and Health Alliance
Texan by Nature
.…sharing the organization’s 2023 Conservation Impact Report on LinkedIn
Texan by Nature, founded by former First Lady Laura Bush in 2011, has released its 2023 Impact Report....